Literature DB >> 10333363

Temporal expression of inducible nitric oxide synthase in mouse and human placenta.

S A Baylis1, P J Strijbos, A Sandra, R J Russell, A Rijhsinghani, I G Charles, C P Weiner.   

Abstract

The aim of this study is to investigate the changes in expression and activity of inducible nitric oxide synthase (iNOS) in the developing murine embryo and mouse and human placenta. Using reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, and in-situ hybridization (ISH) we identified iNOS mRNA in mouse placenta at 9.5, 12, 14, 16, 18 and 20 days post coitum. Northern blot analysis demonstrated that the quantity of murine iNOS transcript was expressed at a stable level between days 12-20 although the level of calcium-independent NOS activity declined with advancing gestation. RT-PCR detected iNOS-specific mRNA in murine embryonic stem cells, but not in embryos at later stages (4-cell or blastocyst). ISH failed to show iNOS-specific mRNA in either murine placenta or the underlying myometrium on day 7, but did so in the trophoblast by day 9.5. Later in gestation, extensive labelling was observed in both spongiotrophoblast and trophoblast giant cells. iNOS mRNA was also detected both in immature human placentae (16-18 weeks) and at term, predominantly in syncytiotrophoblasts and placental artery smooth muscle. In conclusion, iNOS is constitutively expressed in mouse and human placenta at a time and in a location that suggests a role in placentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333363     DOI: 10.1093/molehr/5.3.277

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  6 in total

1.  NADPH-diaphorase activity and nitric oxide synthase isoforms in the trophoblast of Calomys callosus.

Authors:  N Moraes; D Zago; S Gagioti; M S Hoshida; E Bevilacqua
Journal:  J Anat       Date:  2001-04       Impact factor: 2.610

2.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies.

Authors:  T H Hung; J N Skepper; G J Burton
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 3.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

4.  Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.

Authors:  Toshihiro Tanioka; Yoshiaki Tamura; Makiko Fukaya; Shohei Shinozaki; Ji Mao; Minhye Kim; Nobuyuki Shimizu; Tadahiro Kitamura; Masao Kaneki
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

5.  Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells.

Authors:  Amy M Wen; Karin L Lee; Pengfei Cao; Katrina Pangilinan; Bradley L Carpenter; Patricia Lam; Frank A Veliz; Reza A Ghiladi; Rigoberto C Advincula; Nicole F Steinmetz
Journal:  Bioconjug Chem       Date:  2016-04-27       Impact factor: 4.774

Review 6.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.